Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 7:47 PM UTC
| NCT Number | NCT06937229 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE3 |
| Target Enrollment | 650 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT06937229 is currently recruiting participants. This phase3 study for alzheimer's disease is actively seeking new participants at 46 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06937229 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06937229 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.